Tofacitinib Versus Methotrexate as the First Line DMARD in the Treatment of Rheumatoid Arthritis
Clinical trial NCT04464642 · UNKNOWN
Trial details
- NCT number
- NCT04464642
- Sponsor
- Dr. Mohammad Mamun Khan
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-10
- Primary completion
- 2020-08-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.